ELVN

ENLIVEN THERAPEUTICS INC

ELVN·29337E102·US·Common Stock·Healthcare - Biotechnology-Activist

ELVN (ENLIVEN THERAPEUTICS INC) is held by 107 institutional investors as of Q2 2026. Largest holders: FMR LLC ($508.8M), Polar Capital Holdings Plc ($326.4M), BlackRock, Inc. ($221.3M). Net institutional sentiment: Bullish.

107
Holders
(7 Elite)
$2.2B
Total Value
73% (111)
Consensus
81 buying - 30 selling
13F: Insider & Congress: Updated regularly
ELVN

Smart Money Verdict

View all
Loading verdict
Held by 107 funds
7 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Aug 19, 2026 · Activists Aug 6, 2026 · Congress none

InsiderCLCollins Helen LouiseSell $65KAug 17, 2026
InsiderCLCollins Helen LouiseExercise 5K shAug 17, 2026
InsiderCLCollins Helen LouiseSell $228KAug 17, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
10M(+46.8%)$508.8M0.0%+94.64%
43
Increased
6.4M(+26.9%)$326.4M0.8%+107.03%
54
Increased
4.4M(+18.3%)$221.3M0.0%+130.01%
36
Increased
2.6M(+18.5%)$130.4M0.0%+89.12%
35
Increased
2.1M(+18.6%)$105M0.0%+129.86%
35
Increased
1.4M(+32.0%)$71.4M0.0%+117.00%
38
Increased
1.2M(+11.2%)$61.6M0.0%+182.93%
33
Increased
1.2M(+25.0%)$59M0.1%+117.10%
36
New
1.1M$55M0.1%+19.93%
41
Unchanged
905,191$45.9M0.2%+142.96%
0
Increased
905,674(+52.5%)$45.9M0.2%+88.89%
49
Increased
896,161(+16.1%)$35.1M0.0%+93.77%
33
Decreased
671,412(-1.5%)$34.1M0.0%+174.53%
0
Increased
607,189(+95.8%)$30.8M0.0%+54.02%
46
Increased
566,165(+811.5%)$28.7M0.0%+28.50%
46
Increased
562,763(+70.0%)$28.6M0.0%+60.97%
43
New
532,269$27M0.0%+19.93%
40
Decreased
509,928(-1.7%)$25.9M0.0%+185.73%
0
Increased
440,938(+18.4%)$22.4M0.0%+138.68%
33
Increased
424,440(+17.7%)$21.5M0.0%+151.47%
33

Showing 1-20 of 116

1 / 6
ELVNELVNENLIVEN THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used